Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 2
Submit an article Journal homepage
201
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study

Hani HassounMemorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Ruthee BayerNorthwell Health Cancer Institute, Long Island Jewish Medical Center, North Shore University Hospital, the Monter Cancer Center, Lake Success, NY, USA; View further author information
,
Sean DevlinMemorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Theresa GentileUpstate University Hospital, Professor of Medicine, Syracuse, NY, USA; View further author information
,
Michael BeckerAdult Bone Marrow Transplant Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Kristen O’DweyerWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA; View further author information
,
Martin LesserUniversity of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA; View further author information
,
Heather LandauBiostatistics Unit, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; ORCID Iconhttp://orcid.org/0000-0002-3152-1189View further author information
ORCID Icon,
David ChungAdult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA; View further author information
&
Sergio GiraltAdult BMT Service, Melvin Berlin Family Chair in Myeloma Research, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 488-490 | Received 31 Aug 2019, Accepted 20 Sep 2019, Published online: 19 Jan 2020

References

  • Cavo M, Rajkumar SV, Palumbo A, et al. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation. Blood. 2011;117(23):6063–6073.
  • NCCN Clinical Practice Guidelines in Oncology. Multiple Myeloma Version 1.2020. September 6, 2019.
  • McCarthy PL, Owzar K, Hofmeister CC, et al. Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med. 2012;366(19):1770–1781.
  • Attal M, Lauwers-Cances V, Marit G, et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med. 2012;366(19):1782–1791.
  • Palumbo A, Cavallo A, Gay F, et al. Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med. 2014;371(10):895–905.
  • McCarthy PL, Holstein SA, Petrucci MT, et al. Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol. 2017;35(29):3279–3289.
  • D'Souza A, Zhang MJ, Huang J, et al. Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014. Leukemia. 2017;31(9):1998–2000.
  • Chim CS, Kumar SK, Orlowski RZ, et al. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. Leukemia. 2017;32(2):252–262.
  • Alegre A, Granda A, Martinez-Chamorro C, et al. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry. Haematologica. 2002;87(6):609–614.
  • Lenhoff S, Hjorth M, Turesson I, et al. Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation. Haematologica. 2006;91(9):1228–1233.
  • Zamarin D, Giralt S, Landau H. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation. Bone Marrow Transplant. 2013;48(3):419–424.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.